Beranda › Gagal Jantung › Oklahoma
Uji klinis Gagal Jantung di Oklahoma
17 studi untuk Gagal Jantung mencari peserta di lokasi di Oklahoma.
Kota di Oklahoma
Teks studi resmi (Bahasa Inggris)
Early Feasibility Study - Edwards APTURE Transcatheter Shunt System
- Oklahoma Heart Institute, Tulsa
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT03523416A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease
- Oklahoma Heart Institute, Tulsa
Menerima peserta
Usia 18 hingga 85 · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07214376A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
- Research Site, Oklahoma City
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07761117Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
- Oklahoma State University Center for Health Sciences, Tulsa
Menerima pesertaFase 3
Usia 18 hingga 85 · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT06736574Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- South Oklahoma Heart Research, Oklahoma City
Menerima pesertaFase 3
Usia 18 hingga 99 · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT07037459Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
- Research Site, Oklahoma City
- Research Site, Oklahoma City
Menerima pesertaFase 3
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT06677060A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
- Bartlesville, OK Investigative Site 10095, Bartlesville
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Sep 2026 · NCT06008197Pedal Pump Clinical Trial on Edema V2
- Hillcrest Medical Center, Tulsa
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT07809516NORM-HF Pivotal Study
- Saint Francis Health System, Tulsa
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT07574593Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
- Oklahoma Cardiovascular Research Group, Oklahoma City
Menerima peserta
Usia 21 ke atas · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT05677100Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
- Oklahoma City
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 20 Agu 2026 · NCT00271180Alleviant ALLAY-HF Study
- South Oklahoma Heart Research, LLC., Oklahoma City
Menerima peserta
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 14 Agu 2026 · NCT05685303Pedal Pump Clinical Trial on Edema V1
- Hillcrest Medical Center, Tulsa
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 12 Agu 2026 · NCT07760363Assessment of CCM in HF With Higher Ejection Fraction
- Oklahoma Heart Institute, Tulsa
- St. Francis Hospital - Tulsa, Tulsa
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 6 Agu 2026 · NCT05064709Synchronized Diaphragmatic Stimulation in Symptomatic Heart Failure
- Saint Francis Hospital, Tulsa
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Jul 2026 · NCT06552637Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
- Integris Baptist Medical Center, Oklahoma City
- Oklahoma Heart Institute at Utica, Tulsa
- Saint Francis Hospital, Tulsa
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Jun 2026 · NCT06526195The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
- Oklahoma Heart Institute Hospital, Tulsa
- Saint Francis Hospital,, Tulsa
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Apr 2026 · NCT03142152Dari ClinicalTrials.gov, data diambil 3 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.